Results 81 to 90 of about 26,190 (208)

Prognostic Factors of Thymic Carcinoma [PDF]

, 2017
Background: Thymic carcinoma is a rare malignant disease with sparse data for treatment and prognosis. We intended to investigate the prognostic factors of thymic carcinoma.
박인규, 김대준, 정경영
core  

From hepatic to hematopoietic: LRH‐1's expanding cellular repertoire to the immune system

The FEBS Journal, EarlyView.
The nuclear receptor LRH‐1 is a well‐characterized regulator of endodermal tissue. Yet, increasing evidence indicates that LRH‐1, although expressed at low levels, is also a critical regulator of the hematopoietic system. LRH‐1 regulates the immune system by contributing to immune cell‐specific functions.
Lukas Meisinger, Alice Wiedmann, Rayan Hassan M. Elshikhidriss, Thomas Brunner   +3 more
wiley   +1 more source

Carcinoma tímico: a propósito de um caso clínico

Revista Portuguesa de Pneumologia, 2000
RESUMO: Os autores apresentam um caso clinico de carcinoma timico, num bomem de 57 anos, préviamente saudável, que foi enviado á consulta externa de Pneumologia do Hospital de S. João.
Iolanda Mota, António Morais, Pedro Silveira, Isabel Gomes   +3 more
doaj   +1 more source

S‐1 plus cisplatin with concurrent radiotherapy for locally advanced thymic carcinoma: Study protocol of LOGIK1605/JART‐1501

Thoracic Cancer, 2020
Thymic carcinoma is a rare epithelial tumor of the thymus with a poor prognosis, and multimodal approaches are important for its treatment. Recently, a number of studies have indicated that S‐1 treatment is effective against thymic carcinoma.
Minoru Fukuda, Soichiro Funaki, Takuya Yamazaki, Shuntaro Sato, Hiroshi Mukae, Mitsuhiro Takenoyama, Junya Fukuoka, Kazuki Nabeshima, Hisashi Tateyama, Kazuto Ashizawa, Masaki Hara, Takashi Seto, Meinoshin Okumura, Kenji Sugio   +13 more
doaj   +1 more source

OX40/OX40L modulation: A target for regulating T cells in cutaneous inflammatory disorders

Journal of the European Academy of Dermatology and Venereology, EarlyView.
OX40 and OX40L are a co‐stimulatory immune checkpoint pair. Modulation of this pair impacts multiple immune phenotypes and is an attractive target for immunotherapy in dermatological disorders. Trials are underway with the majority in atopic dermatitis and currently in phase 3 trials.
Aditya K. Gupta, Julia Steriopoulos, Vasiliki Economopoulos, Paradi Mirmirani, Vincent Piguet   +4 more
wiley   +1 more source

Thymus and Leishmania at the Crossroads: Autoimmunity and Cancer

Immunology, Volume 178, Issue 3, Page 377-386, July 2026.
Conceptual ‘Crossroads Model’ linking Leishmania, thymic infection and immune dysregulation: an integrative model is proposed in which Leishmania infection disrupts thymic architecture and stromal–thymocyte interactions. These alterations converge to promote defective tolerance, increased autoimmune risk and a microenvironment permissive to malignant ...
Alef Batista Bezerra Barros, Gabriel Augusto Leite, Arthur Gomes de Andrade, Maria Danielma dos Santos Reis, Luiz Henrique Agra Cavalcante‐Silva, Marvin Paulo Lins   +5 more
wiley   +1 more source

Durable Response to Lenvatinib in Platinum-Refractory Metastatic High-Grade Thymic Mucoepidermoid Carcinoma: A Case Report

JTO Clinical and Research Reports
Thymic mucoepidermoid carcinoma (MEC) is a rare thymic carcinoma subtype. Current metastatic thymic carcinoma guidelines recommend first-line platinum-based chemotherapy.
Noa Amin, PhD, MRCP, Thanika Ketpueak, DM, Simon Jordan, MBBCh, MD, Andrew G. Nicholson, DM, FRCPath, Yu Zhi Zhang, MBBS, PhD, FRCPath, Sanjay Popat, PhD FRCP   +5 more
doaj   +1 more source

Novel biomarkers for thymic carcinoma

, 2019
Thymic carcinoma (TC), the rarer among Thymic Epithelial Tumors (TET), occur with an incidence rate of 0.2-0.5/million/yr. Difficulties in the evaluation of molecular aspects derive from the extreme rarity of these tumors.
Casini, B., Laquintana, V., Facciolo, F., Pescarmona, E., Melis, E., Gallo, E., Cerasoli, V., Fazi, F., Cecere, F., Marino, M.   +9 more
core   +1 more source

Multi‐omics insights for deciphering prognosis‐related T cell subsets in hepatocellular carcinoma

Clinical and Translational Medicine, Volume 16, Issue 6, June 2026.
An integrated multi‐omics analysis delineates the prognostic landscape of T‐cell subsets in hepatocellular carcinoma. DPT cells and HBEGF‐related signals are associated with poor survival in hepatocellular carcinoma. Endothelial‐derived HBEGF recruits DPT cells, which in turn up‐regulate the EMT signatures and drive the migration of hepatocellular ...
Guangzu Cui, Erya Hu, Qingping Peng, Xin Zhou, Yu Zhao, Haicong Liu, Xinwen Wang, Yihong Chen, Hong Shen, Shan Zeng, Jiayao Ma   +10 more
wiley   +1 more source

Evaluation of anterior mediastinal solid tumors by CT perfusion: a preliminary study

Diagnostic and Interventional Radiology, 2017
PURPOSE:We aimed to assess the role of computed tomography (CT) perfusion in differentiation of thymoma from thymic hyperplasia, lymphoma, thymic carcinoma, and lung cancer invading anterior mediastinum.METHODS:In this study, 25 patients with an anterior
Selim Bakan, Sedat Giray Kandemirli, Atilla Süleyman Dikici, Ezel Erşen, Onur Yıldırım, Cesur Samancı, Şebnem Batur, Deniz Çebi Olgun, Fatih Kantarcı, Canan Akman   +9 more
doaj   +1 more source